Citations

Clear

361 citation(s) found for "Bauer, M".

Tai Chi for patients with mild cognitive impairment
Yang, Juan , Chon, Tony Y. , Li, Guangxi , Mallory, Molly J., Bublitz, Sara E. , Do, Alexander , Xiao, Lizu, Xiong, Donglin, Bauer, Brent A. , Li, Guangxi

Mayo Clinic

Medicine | October 2, 2019 | Volume: 98 | Issue: 40 | Pages: e17118

10.1097/md.0000000000017118 | PMID 31577701 Get It

Abstract Background: Mild cognitive impairment (MCI) is an intermediate stage between the cognitive changes of normal aging and early dementia. Tai Chi (TC) may be particularly beneficial to patients with MCI due to its whole-body coordination characteristics. This systematic review protocol aims to outline the methods that will be used to assess the comparative effectiveness and safety of TC for MCI through a systematic review and meta-analysis. Methods: A systematic review will identify and evaluate randomized controlled trials (RCTs) that examined the effects and safety of TC compared to a placebo, conventional treatment, and no treatment on cognitive function in individuals with MCI. Studies from databases of MEDLINE, PubMed, Embase, Global Health, Cochrane Library, and Scopus from January 1990 to March 2019 reported in English will be searched. Two independent reviewers will screen the studies for inclusion with the eligibility criteria and extract data. Risk of bias of individual studies will be assessed in line with Cochrane risk of bias tool. The overall quality of cumulative evidence will be assessed using selected Grading of Recommendations, Assessment, Development, and Evaluations criteria. Statistics will be used for heterogeneity assessment, sensitivity analysis, data synthesis, generating funnel plots, and subgroup analysis. Meta-analysis will be performed, if sufficiently homogeneous studies are found. A narrative synthesis will be conducted, grouping studies by exposure and outcome definitions, and describing any differences by subgroups. Results: This study will provide practical and targeted evidence in investigating the impact of TC exercise for individuals with MCI. Conclusion: The findings of our study will provide updated evidence to determine whether TC is an effective intervention to patients with MCI. Trial registration number: International Prospective Register for Systematic Reviews (PROSPERO) number CRD42019125104.
Sarcopenia: A Time for Action. An SCWD Position Paper
Bauer, Jürgen M. , Morley, John E. , Schols, Annemie M.W.J. , Ferrucci, Luigi , Cruz‐Jentoft, Alfonso J. , Dent, Elsa , Crawford, Jeffrey A., Doehner, Wolfram , Jatoi, Aminah , Kalantar‐Zadeh, Kamyar, Landi, Francesco , Laviano, Alessandro , Muscaritoli, Maurizio , Prado, Carla M. , Strasser, Florian, Haehling, Stephan von , Kalantar-Zadeh, Kamyar , Ferrucci, Luigi , Baracos, Vickie E. , Heymsfield, Steven B. , Lainščak, Mitja , Mancuso, Michelangelo , Coats, Andrew J.S. , Anker, Stefan D. , Doehner, Wolfram , Kalantar-Zadeh, Kamyar

Mayo Clinic

Journal of Cachexia, Sarcopenia and Muscle | September 16, 2019 | Volume: 10 | Issue: 5 | Pages: 956-961

10.1002/jcsm.12483 | PMID 31523937 Get It

Abstract The term sarcopenia was introduced in 1988. The original definition was a “muscle loss” of the appendicular muscle mass in the older people as measured by dual energy x‐ray absorptiometry (DXA). In 2010, the definition was altered to be low muscle mass together with low muscle function and this was agreed upon as reported in a number of consensus papers. The Society of Sarcopenia, Cachexia and Wasting Disorders supports the recommendations of more recent consensus conferences, i.e. that rapid screening, such as with the SARC‐F questionnaire, should be utilized with a formal diagnosis being made by measuring grip strength or chair stand together with DXA estimation of appendicular muscle mass (indexed for height2). Assessments of the utility of ultrasound and creatine dilution techniques are ongoing. Use of ultrasound may not be easily reproducible. Primary sarcopenia is aging associated (mediated) loss of muscle mass. Secondary sarcopenia (or disease‐related sarcopenia) has predominantly focused on loss of muscle mass without the emphasis on muscle function. Diseases that can cause muscle wasting (i.e. secondary sarcopenia) include malignant cancer, COPD, heart failure, and renal failure and others. Management of sarcopenia should consist of resistance exercise in combination with a protein intake of 1 to 1.5 g/kg/day. There is insufficient evidence that vitamin D and anabolic steroids are beneficial. These recommendations apply to both primary (age‐related) sarcopenia and secondary (disease related) sarcopenia. Secondary sarcopenia also needs appropriate treatment of the underlying disease. It is important that primary care health professionals become aware of and make the diagnosis of age‐related and disease‐related sarcopenia. It is important to address the risk factors for sarcopenia, particularly low physical activity and sedentary behavior in the general population, using a life‐long approach. There is a need for more clinical research into the appropriate measurement for muscle mass and the management of sarcopenia. Accordingly, this position statement provides recommendations on the management of sarcopenia and how to progress the knowledge and recognition of sarcopenia.
Best Practices for Systematic Case Review in Collaborative Care
Bauer, Amy M. , Williams, Mark D. , Ratzliff, Anna , Unützer, Jürgen

Mayo Clinic

Psychiatric Services | August 27, 2019 | Volume: 70 | Issue: 11 | Pages: 1064-1067

10.1176/appi.ps.201900085 | PMID 31451067 Get It

Experience and expectations of patients on weight loss: The Learning Health System Network Experience
DeJesus, Ramona S. , Bradley, David , Haller, Irina V. , Schroeder, Darrell R. , Sauver, Jennifer L. St. , Phelan, Sean M. , Croghan, Ivana T. , DeJesus, R S , Phelan, S M , St Sauver, Jennifer L , Schroeder, Darrell , Bauer, Katherine W. , Bradley, Steven M.

Mayo Clinic

Obesity Science & Practice | July 26, 2019 | Volume: 5 | Issue: 5 | Pages: 479-486

10.1002/osp4.364 | PMID 31687172 Get It

SummaryObjectiveWeight perception and degree of confidence in achieving healthy lifestyle can be determinants of engagement in obesity interventions. This study explored patients' perceived need for weight loss and the degree of self‐confidence in ability to lose weight and sought to identify factors associated with patients' self‐confidence in ability to lose weight.MethodsThe authors analysed data from a survey mailed to primary care patients within five sites of the Learning Health Systems Network that explored participants' prior experience with weight management.ResultsAmong the 2,263 participants who completed the survey section on ‘Patients’ Experience with Weight Management’, perceived need to lose 51 lb or more was statistically significant among those with class III obesity compared with other body mass index (BMI) groups (p value < 0.001). Reported desire to lose weight was also significantly higher among those with the highest BMI than those who were overweight (p value < 0.001). However, this same group had the lowest belief in ability to lose weight (p value < 0.001). In a multiple regression analysis, female gender, higher BMI and need to lose >10 lb were each independently associated with less belief in being able to lose weight.ConclusionsPatients had varying perceptions on weight loss; those with category III obesity had the highest desire to lose weight but had the least confidence in ability to lose weight. Higher BMI, female gender and need to lose >10 lb were associated with decreased self‐confidence in ability to lose weight.
Use of Acupuncture in Overweight/Obese Women with Polycystic Ovary Syndrome
Yang, Juan , Chon, Tony Y. , Bauer, Brent A.

Mayo Clinic

Medical Acupuncture | July 22, 2019 | Volume: 31 | Issue: 5 | Pages: 267-268

10.1089/acu.2019.1375 | PMID 31624524 Get It

Acupuncture: Real-world patient-reported outcomes of treatment-related symptoms in breast cancer survivors.
Zayas, Jacqueline , Ruddy, Kathryn J. , Bauer, Brent A. , Mallory, Molly J., Zahrieh, David M. , Loprinzi, Charles L. , Olson, Janet E. , Couch, Fergus J. , Yang, Ping , Cathcart-Rake, Elizabeth

Mayo Clinic

Journal of Clinical Oncology | May 28, 2019 | Volume: 37 | Issue: 15_suppl | Pages: e23111-e23111

10.1200/jco.2019.37.15_suppl.e23111 Get It

e23111 Background: Acupuncture has been shown to reduce aromatase inhibitor-induced arthralgias, as well as possibly hot flashes and fatigue, but research has been limited. The purpose of this study was to evaluate real world perceived benefit of acupuncture for commonly experienced symptoms among breast cancer survivors. Methods: Breast cancer survivors who had used acupuncture for cancer- or treatment-related symptoms were identified using an ongoing prospective Mayo Clinic Breast Disease Registry (MCBDR) cohort. In addition, Mayo Clinic electronic health records (EHR) were queried to identify additional participants. All identified patients were mailed a survey with acupuncture-related questions. Respondents were also asked to recall their severity of arthralgia, myalgia, post-surgical pain, hot flashes, nausea/vomiting, fatigue, depression, anxiety, insomnia, lymphedema, headache, and neuropathy from 1 to 5 (1 = mild, 5 = severe) before and after acupuncture treatment. Results: Acupuncture use was reported among 413 participants in MCBDR (12% of all enrollees) and 73 patients were identified in the Mayo EHR. 241 eligible women returned surveys (median age at diagnosis 50 yrs). Mean symptom severity scores decreased from before to after acupuncture by at least 1 point for all queried symptoms (Table). Conclusions: Acupuncture is frequently used by patients for a variety of breast cancer-related symptoms. Those who do pursue acupuncture usually perceive few toxicities and substantial benefits. Cost may be a barrier to treatment for some. [Table: see text]
High frequency of HER2-specific immunity observed in patients (pts) with HER2+ cancers treated with margetuximab (M), an Fc-enhanced anti-HER2 monoclonal antibody (mAb).
Nordstrom, Jeffrey L., Muth, John, Erskine, Courtney L. , Sanders, Catherine , Yusko, Erik, Emerson, Ryan , Lee, Min-Jung , Trepel, Jane B. , Bang, Yung‐Jue, Burris, Howard A. , Baughman, Jan, Rock, Edwin P. , Moore, Paul A. , Bonvini, Ezio , Knutson, Keith L. , Lee, Sunmin , Im, Seock‐Ah , Bang, Yung‐Jue , Giaccone, Giuseppe , Bauer, Todd Michael , Knutson, Keith L.

Mayo Clinic

Journal of Clinical Oncology | May 27, 2019 | Volume: 37 | Issue: 15_suppl | Pages: 1030-1030

10.1200/jco.2019.37.15_suppl.1030 Get It

1030 Background: Previous studies have shown that 44-71% of trastuzumab (T)-treated pts develop HER2-specific immunity (Clin Cancer Res 2007, 13:5133; Cancer Res 2016, 76:3702; Breast Cancer Res 2018, 20:52). M is an Fc-engineered mAb that shares similar HER2 binding and antiproliferative activity as T. The Fc region of M has been engineered for increased affinity to the activating FcγRIIIA (CD16A) and lower binding to the inhibitory FcγRIIB (CD32B), attributes that may enhance the mAb’s immune function, such as antigen presentation. Methods: HER2+ cancer pts who progressed on prior therapy received M (0.1-6 mg/kg QW for 3 of every 4 weeks [N = 34]; or 10-18 mg/kg Q3W [N = 32]) in phase 1 trial NCT01148849. PBMC and plasma were collected pre-dose and 50 days post-dose for 46 pts and > 4 years for 3 pts on long-term treatment. Response to HER2 or control antigens (Ag) was assessed by IFNγ ELISpot and antibody (Ab) ELISA. In 14 pts, T-cell antigen receptor (TCR) repertoire was assessed by immunosequencing. Results: Following M treatment, mean frequencies of IFNγ-producing T cells specific for intra- or extracellular fragments of HER2 increased by 2.5 to 6-fold (p < 0.0027, paired t test). Most (95%) of subjects responded to ≥2 of 6 (median = 5) HER2 Ag. Mean HER2-specific Ab concentration increased by 19-54% (p < 0.0001), with all subjects responding to ≥2 (median = 5) of the 6 Ag. A small 1.6-fold increase in IFNγ response to control CMV/EBV/Flu (but not tetanus or cyclin D1) peptides was observed; no increase in Ab response to control Ag was noted. Subsets of HER2-specific T-cell and Ab responses persisted during long-term treatment. Median TCR clonality increased by 54% (p = 0.003), with an average of 125 unique clones expanding, while overall TCR diversity remained unchanged (p = 0.19). Conclusions: Treatment of HER2+ cancer with M was associated with enhanced HER2-specific T-cell and Ab responses together with increased TCR clonality, indicative of a more focused T-cell repertoire. The high frequency of HER2-specific immunity in M-treated patients ( > 95%) is consistent with its enhanced Fc region contributing to linkage of innate and adaptive immune responses.
Resolution of Postsurgical Diplopia, Paresthesia, and Weakness Following Inpatient Massage Therapy: A Case Report
Hauschulz, Jennifer L. , Clark, Stephanie , Bauer, Brent A. , Chon, Tony Y. , Hauschulz, Jennifer , Bauer, Brent, Chon, Tony

Mayo Clinic

Global Advances in Health and Medicine | May 16, 2019 | Volume: 8 | Issue: No issue available | Pages: No page available

10.1177/2164956119852396 | PMID 31192054 Get It

Massage therapy is utilized in hospitals for patients experiencing pain, anxiety, sleeplessness, among other symptoms. Postsurgical pain is one of the most common reasons massage therapy is ordered. We present a case of a 45-year-old woman who underwent ventral hernia repair. Postoperative day 2, she began to experience multiple symptoms, including double-vision, left-sided facial numbness, tremors, pain, and weakness in her left fingers, arm, and leg. A static magnetic resonance image of the brain and cervical spine were obtained, which revealed disc protrusions at C3/C4, C5/C6, C6/C7, and mild deformity of the spinal cord. The patient’s pain was difficult to control and she was unable to be weaned from intravenous pain medication. Massage therapy was ordered on postoperative days 6 and 7. During both massage sessions, as upper neck muscle tension was reduced, the therapist and patient observed several audible “pops” of the cervical spine with immediate relief of symptoms. In this particular case, massage therapy, though requested to address pain, had a secondary benefit in relieving her diplopia, left-sided facial numbness, tremors, and weakness. Although the mechanism of action is not clear, this case highlights the significant secondary beneficial effects that often occur with massage therapy.